https://moleculin.com/
Home - Moleculin
https://www.prnewswire.com/news-releases/investor-alert-kaplan-fox-investigates-moleculin-biotech-inc-301055987.html
Investor Alert: Kaplan Fox Investigates Moleculin Biotech, Inc.
investor alertkaplanfoxinvestigatesbiotech
https://www.prnewswire.com/news-releases/moleculin-to-present-antitumor-activity-of-annamycin-in-combination-with-ara-c-in-aml-at-american-society-for-hematology-annual-conference-301185191.html
Moleculin To Present Antitumor Activity of Annamycin in Combination with Ara-C in AML at American...
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug...
https://www.prnewswire.com/news-releases/moleculin-receives-first-country-approval-in-europe-to-begin-recruiting-for-the-miracle-phase-3-rr-acute-myeloid-leukemia-aml-pivotal-trial-302372939.html
Moleculin Receives First Country Approval in Europe to Begin Recruiting for the MIRACLE Phase 3 R/R...
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad portfolio of drug...
https://www.prnewswire.com/news-releases/moleculin-provides-additional-comments-regarding-trading-halt-301056411.html
Moleculin Provides Additional Comments Regarding Trading Halt
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of...
providesadditionalcommentsregardingtrading
https://www.prnewswire.com/news-releases/moleculin-announces-nasdaq-trading-halt-pending-receipt-of-additional-information-301060576.html
Moleculin Announces Nasdaq Trading Halt Pending Receipt of Additional Information
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of...
nasdaq tradingannounceshaltpendingreceipt